Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics (BIPass II)

Prognostic Study of Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease Based on Metabolomics, and Lipidomics

To investigate whether there were differences in metabolomics and lipidomics in patients with coronary artery disease who had major adverse cardiovascular events during follow-up compared with those who did not.

Inclusion Criteria:

1. Hospitalized patients with the diagnosis of any type of coronary artery disease;
2. Age ≥18 years of age;
3. Patient or guardian provided informed written consent.

Exclusion Criteria:

1. Prior surgery, trauma or clinically evident coagulopathic bleeding within the previous 2 weeks;
2. Bipass population with missing follow-up records in Qilu Hospital emergency follow-up cohort.